Novocure Appoints Pritesh Shah as Chief Commercial Officer

Novocure announced that Pritesh Shah has been appointed as Novocure’s Chief Commercial Officer, reporting to Novocure’s Chief Executive Officer Asaf Danziger. In this role, Shah will be responsible for the development and execution of Novocure’s commercialization strategy worldwide, and for overseeing Novocure’s international business units. Shah joined Novocure in 2012 as the Senior Director of Global Marketing and progressed through a series of roles of greater responsibilities within the commercial organization. Most recently, he acted as Senior Vice President of the Americas. Prior to joining Novocure, Pritesh had extensive experience in the oncology field, including roles at Roche, Genentech, Bristol-Myers Squibb, OSI Oncology and AVEO.

Pritesh holds a Doctor of Pharmacy from the University of Maryland and a master’s degree in Strategic Communication and Leadership from Seton Hall University. “Throughout his time here, Pritesh has demonstrated an inclusive, direct and transparent leadership style that has helped build cohesion and foster an environment of collaboration,” Danziger said. “He has exemplified a passion for developing people and teams while aligning individuals and teams toward our patient-forward mission. I welcome Pritesh to our executive team and am eager to see what our team will accomplish moving forward.” – Medical Buyer Bureau